EX-104 (Guangzhou ExcelMab)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameEX-104 (Guangzhou ExcelMab)

Drug Alias NameEX-104EX104

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionT cell immunoglobulin and ITIM domains inhibitorsProgrammed cell death protein 1 antagonistsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects +[4]

TargetsT cell immunoglobulin and ITIM domainsProgrammed cell death protein 1

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesGuangzhou Excelmab Inc

China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Excelmab Inc

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A